Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IMO Schwartz stock sales may be the key that unravels this conundrum
Reply New Message
Prev Message Back To Forum Threaded View Next Message
... Thus my guess is, IF the licensee's lawyers point to the PTSC financials, TPL must have something in their pockets to convince them - how could they otherwise negotiate with potential infringers?
I hope, I could make my point a little clearer - maybe I'm fresher tomorrow - good night from Germany!
First of all, I appreciate your logic and effort. Secondly, to your above point, my WAG is that TPL has the bulk of the settlement money in their pockets. If they have nobody to answer to or not legally obligated to publicly state thier income, it affords them much latitiude to pilfer the coffers.
1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply